Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Updates in Surgery
Published in: Updates in Surgery 2/2022

01-04-2022 | Metastasis | Original Article

Which surgical strategy for colorectal cancer with synchronous hepatic metastases provides the best outcome? A comparison between primary first, liver first and simultaneous approach

Authors: Fabio Carbone, Yinshan Chee, Shahnawaz Rasheed, David Cunningham, Ricky Harminder Bhogal, Long Jiao, Paris Tekkis, Christos Kontovounisios

Published in: Updates in Surgery | Issue 2/2022

Login to get access

Abstract

Background

There is no clear consensus about the best surgical strategy for patients with colorectal cancer (CRC) and synchronous liver metastases (SCRLM).

Methods

Between 2009 and 2019, patients with CRC and SCRLM considered for curative treatment were included. Perioperative and follow-up data were analysed to examine the safety and survival outcomes of primary first (PF), liver first (LF) and simultaneous resection (SR) strategies.

Results

204 patients were identified, consisting of PF (n = 129), LF (n = 26) and SR (n = 49). Forty-five patients (22.1%) failed to have either the primary or the liver metastases resected following initial LF (n = 11, 42.3%) or PF (n = 34, 26.4%), respectively (p < 0.001). The postoperative morbidity rates were 31.0%, 38.4% and 40.8% in PF, LF and SR group, respectively (p = 0.409); the mortality rates were 2.3%, 0% and 4.1%, respectively (p = 0.547). The 1-, 3- and 5-year overall survival (OS) were 94%, 72%, 53% in the PF group, 74%, 54%, 36% in the LF group, and 91%, 74%, 63% in the SR group. LF group had the worst OS compared to PF and SR (p = 0.040, p = 0.052). The 1-, 3- and 5-year disease-free survival (DFS) were 31%, 15%, 10% in PF, 21%, 9% and 9% in LF and 45%, 28% and 28% in SR group, respectively. SR group had a better DFS compared to PF and LF (p = 0.005, p = 0.008). At the multivariate analysis, there was no difference between the three strategies in terms of OS (PF vs SR OS-HR 1.090, p = 0.808; LF vs SR OS-HR 1.582, p = 0.365) and the PF had a worse DFS compared to the SR approach (PF vs SR DFS-HR 1.803, p = 0.007; LF vs SR DFS-HR 1.252, p = 0.492).

Conclusions

PF, LF and SR had comparable postoperative morbidity and mortality. The three surgical strategies had similar OS outcomes. The PF strategy was associated with a worse DFS than SR, while the LF approach was associated with a high failure rate to progress to the second stage (primary tumour resection).
Appendix
Available only for authorised users
Literature
1.
Adam R, de Gramont A, Figueras J et al (2015) Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev 41(9):729–741CrossRef
2.
van der Pool AE, Damhuis RA, Ijzermans JN et al (2012) Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis 14(1):56–61CrossRef
3.
Chow FC, Chok KS (2019) Colorectal liver metastases: an update on multidisciplinary approach. World J Hepatol 11(2):150–172CrossRef
4.
Wanis KN, Pineda-Solis K, Tun-Abraham ME et al (2017) Management of colorectal cancer with synchronous liver metastases: impact of multidisciplinary case conference review. Hepatobiliary Surg Nutr 6(3):162–169CrossRef
5.
Weledji EP (2017) Centralization of liver cancer surgery and impact on multidisciplinary teams working on stage IV colorectal cancer. Oncol Rev 11(2):331PubMedPubMedCentral
6.
Collins D, Chua H (2017) Contemporary surgical management of synchronous colorectal liver metastases. F1000Res 6:598CrossRef
7.
von Elm E, Altman DG, Egger M et al (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 12(12):1495–1499CrossRef
8.
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRef
9.
Agarwal GG (2012) Statistics for surgeons—understanding survival analysis. Indian J Surg Oncol 3(3):208–214CrossRef
10.
de Haas RJ, Adam R, Wicherts DA et al (2010) Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg 97(8):1279–1289CrossRef
11.
Slesser AAP, Chand M, Goldin R, Brown G, Tekkis PP, Mudan S (2013) Outcomes of simultaneous resections for patients with synchronous colorectal liver metastases. Eur J Surg Oncol 39(12):1384–1393CrossRef
12.
Bogach J, Wang J, Griffiths C et al (2020) Simultaneous versus staged resection for synchronous colorectal liver metastases: a population-based cohort study. Int J Surg 74:68–75CrossRef
13.
Nitsche U, Weber C, Kaufmann B et al (2020) Simultaneous versus staged resection of colorectal cancer liver metastasis: a retrospective single-center study. J Surg Res 255:346–354CrossRef
14.
Valdimarsson VT, Syk I, Lindell G et al (2020) Outcomes of simultaneous resections and classical strategy for synchronous colorectal liver metastases in Sweden: a nationwide study with special reference to major liver resections. World J Surg 44(7):2409–2417CrossRef
15.
Wang LJ, Wang HW, Jin KM, Li J, Xing BC (2020) Comparison of sequential, delayed and simultaneous resection strategies for synchronous colorectal liver metastases. BMC Surg 20(16):1–9
16.
Thelen A, Jonas S, Benckert C et al (2007) Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis 22(10):1269–1276CrossRef
17.
Martin RC, Augenstein V, Reuter NP, Scoggins CR, McMasters KM (2009) Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg 208(5):842–850CrossRef
18.
Boudjema K, Locher C, Sabbagh C et al (2021) Simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases: a prospective, open-label, randomized, controlled trial. Ann Surg 273(1):49–56CrossRef
19.
Giuliante F, Viganò L, De Rose AM et al (2021) Liver-first approach for synchronous colorectal metastases: analysis of 7360 patients from the LiverMetSurvey registry. Ann Surg Oncol 28(13):8198–8208CrossRef
20.
Roberts KJ, White A, Cockbain A et al (2014) Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases. Br J Surg 101(7):856–866CrossRef
21.
Kumar R, Dennison AR, Robertson V, Jones MJ, Neal CP, Garcea G (2018) Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases. ANZ J Surg 88(1–2):E16–E20CrossRef
22.
Labori KJ, Guren MG, Brudvik KW et al (2017) Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival. Colorectal Dis 19(8):731–738CrossRef
23.
Gall TM, Basyouny M, Frampton AE et al (2014) Neoadjuvant chemotherapy and primary-first approach for rectal cancer with synchronous liver metastases. Colorectal Dis 16(6):O197-205CrossRef
24.
Martin R, Paty P, Fong Y et al (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197(2):233–241CrossRef
25.
Le Souder E, Azin A, Wood T et al (2018) The effect of a simultaneous versus a staged resection of metastatic colorectal cancer on time to adjuvant chemotherapy. J Surg Oncol 118(1):86–94CrossRef
26.
Silberhumer GR, Paty PB, Temple LK et al (2015) Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg 209(6):935–942CrossRef
27.
Gavriilidis P, Katsanos K, Sutcliffe RP, Simopoulos C, Azoulay D, Roberts KJ (2019) Simultaneous, delayed and liver-first hepatic resections for synchronous colorectal liver metastases: a systematic review and network meta-analysis. J Clin Med Res 11(8):572–582CrossRef
28.
She WH, Chan AC, Poon RT et al (2015) Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection? ANZ J Surg 85(11):829–833CrossRef
Metadata
Title
Which surgical strategy for colorectal cancer with synchronous hepatic metastases provides the best outcome? A comparison between primary first, liver first and simultaneous approach
Authors
Fabio Carbone
Yinshan Chee
Shahnawaz Rasheed
David Cunningham
Ricky Harminder Bhogal
Long Jiao
Paris Tekkis
Christos Kontovounisios
Publication date
01-04-2022
Publisher
Springer International Publishing
Published in
Updates in Surgery / Issue 2/2022
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-021-01234-w

Other articles of this Issue 2/2022

Updates in Surgery 2/2022 Go to the issue

Original Article

Application of competing risk model in the prognostic prediction study of patients with follicular thyroid carcinoma

Letter to the Editor

Letter to editor: “Sim life model: introducing a new teaching device in endocrine surgery simulation”

Original Article

Neoadjuvant chemotherapy with S-1 plus cisplatin for esophageal squamous cell carcinoma

Review Article

Can you trust clinical practice guidelines for laparoscopic surgery? A systematic review of clinical practice guidelines for laparoscopic surgery

Editorial and Commentary

Nullius in Verba

Original Article

Influence of incorrect staging of colorectal carcinoma on oncological outcome: are we playing safely?